Welcome to Immortality Is Here

Welcome to the Longevity Knowledge Center — your trusted source for clear, science-based insights into the biology of aging and the strategies to overcome it.

This is not hype. This is your roadmap to surviving—and thriving—into the era of radical life extension.

Whether you’re longevity-curious, health-optimized, or building your own protocol, this section will help you go from overwhelmed… to enlightened.

Living Long Enough To Live Forever

Top

Longevity Clinical Trial Tracker

Immortality is Here / The Longevity Toolbox / Longevity Clinical Trial Tracker

🔬 Follow the Front Lines of Anti-Aging Science—In Real Time

What if you could see every human trial related to longevity happening right now—organized, searchable, and explained in plain language?

That’s exactly what the Longevity Trial Tracker offers.

This tool gives you an up-to-date, curated dashboard of active and recent clinical trials focused on aging, rejuvenation, and lifespan extension. It filters out the noise and gives you the signal: what’s being tested, where, by whom, and what it could mean for the future of healthspan.


🧠 Why This Tool Matters

The science of longevity is moving faster than ever—but unless you’re fluent in PubMed and spend hours on ClinicalTrials.gov, you’re probably missing breakthroughs.

The Trial Tracker:

  • Keeps you ahead of the curve
  • Highlights the most promising interventions
  • Shows which companies and institutions are leading the charge
  • Gives you the option to join certain trials if eligible
  • Builds context between research and products you see in the Longevity Directory

🔍 What’s Included in Each Trial Card

FieldExample
Title“Rapamycin for Lifespan Extension in Healthy Adults”
StatusRecruiting / Active / Completed
PhaseI / II / III
SponsorBuck Institute for Research on Aging
Intervention TypemTOR inhibitor (Rapamycin)
Primary OutcomeChange in epigenetic age after 12 weeks
Estimated CompletionApril 2025
LocationSan Diego, CA
EligibilityAge 40–65, BMI < 30, no major illness
Link to DetailsClinicalTrials.gov NCT045XXXXXX

Each entry also includes a 1–2 sentence plain-language summary, and a link to related articles in the Knowledge Center (e.g., “Read more on mTOR and aging”).


🧬 Intervention Categories Tracked

  • Senolytics & senomorphics
  • mTOR modulators (e.g., Rapamycin)
  • NAD+ precursors (NMN, NR)
  • Cellular reprogramming (Yamanaka factors)
  • Epigenetic age reversal
  • Stem cell or exosome therapies
  • AKG, glycine/NAC, and other longevity nutraceuticals
  • Caloric restriction mimetics
  • Immunosenescence & thymic regeneration
  • Microbiome-targeted longevity interventions
  • Whole-body rejuvenation trials
  • Cryoprotection & biostasis (early phase)
  • Digital immortality / neuro-interface experiments (coming soon)

🔎 Filter Options (UI Features)

  • ✅ Trial phase (I, II, III)
  • 🔍 Search by keyword or intervention
  • 🏥 Sponsor/institution (e.g., NIH, Altos Labs, Calico)
  • 🧪 Mechanism (mTOR, senolytic, NAD+, etc.)
  • 📍 Location or country
  • 🗓️ Active vs completed trials
  • 💡 “Most Impact Potential” score (evidence + novelty)

📈 Why Use the Trial Tracker

  • Get a pulse on where science is headed
  • Discover companies from the Directory involved in trials
  • Track clinical validation of supplements or drugs you’re considering
  • Identify human evidence behind interventions you already use
  • Bookmark promising trials to follow long-term
  • Join a trial if you meet criteria (with guidance on how)

🔐 Ethics & Transparency

  • We only include IRB-approved, registry-listed trials
  • No “off-book” or anecdotal studies
  • We don’t receive payment for inclusion
  • All trial data is sourced via ClinicalTrials.gov, EU-CTR, and WHO ICTRP, and refreshed weekly

🧰 Coming Soon Enhancements

  • “Follow this Trial” button → get updates when status changes
  • Monthly Trial Spotlight article
  • Overlay of completed trial data with product launches
  • AI-powered plain-English summaries of published results
  • Personal dashboard of trials you follow or match eligibility for

🚀 Track the Future—Today

The Longevity Trial Tracker is part of the Toolbox Beta, launching soon. You’ll be able to explore trials, understand their impact, and connect science to your everyday decisions.

👉 Join the Newsletter for early access.